ROBERT STERN: Open Payments
NPI 1134272495 · STATEN ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 24 payments from 11 companies in 2025. Trend: 2023 $9,683 · 2024 $4,367 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 7 | $141 |
| Lilly USA, LLC | 3 | $68 |
| Neurocrine BioSciences, Inc. | 3 | $60 |
| Eisai Inc. | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Lundbeck LLC | 1 | $19 |
| Life Molecular Imaging Ltd | 1 | $17 |
Products named: SPRAVATO, AMYVID, INGREZZA, INVEGA SUSTENNA, Leqembi, COBENFY, AUSTEDO XR, TRINTELLIX.
Industry payments across NY — which companies pay providers there.
